» Authors » Michal J Sobieszczyk

Michal J Sobieszczyk

Explore the profile of Michal J Sobieszczyk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 25
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wells C, ONeil E, Sobieszczyk M, Marcus J
Am J Infect Control . 2025 Feb; PMID: 39947521
Background: Coagulase-negative Staphylococci (CoNS) are frequently cited as the most common cause of bacteremia in patients receiving extracorporeal membrane oxygenation (ECMO), yet there is significant variability in reporting rates between...
2.
Houle M, Sobieszczyk M, Warren W, Hunninghake J, Anderson J, Gonzales M, et al.
Artif Organs . 2024 Nov; 49(3):353-361. PMID: 39578938
Background: Casualties of military conflicts suffer a multitude of injuries, and recent research has documented a significant number develop acute respiratory distress syndrome (ARDS). The present study undertakes a scoping...
3.
Wells C, Sobieszczyk M, Marcus J
Mil Med . 2024 Sep; PMID: 39331069
Introduction: Nosocomial infections are frequent in patients receiving extracorporeal membrane oxygenation (ECMO). Leukemoid reaction, defined as >50,000 white blood cells (WBCs) per microliter, has been associated with infections in some...
4.
Patel K, Aden J, Sobieszczyk M, Marcus J
Ther Adv Infect Dis . 2024 Jun; 11:20499361241255873. PMID: 38883923
Background: Identifying secondary infections in patients receiving extracorporeal membrane oxygenation (ECMO) presents challenges due to the ECMO circuit's influence on traditional signs of infection. Objectives: This study evaluates procalcitonin as...
5.
Laverty R, Ivins-OKeefe K, Adams A, Flatley M, Sobieszczyk M, Mason P, et al.
Mil Med . 2023 Dec; 189(5-6):e1016-e1022. PMID: 38079460
Introduction: The incidence and management outcomes of COVID-19 patients with acute respiratory distress syndrome (ARDS) on veno-venous extracorporeal membrane oxygenation (V-V ECMO) requiring chest tubes are not well-described. This study...
6.
Jackson L, Sobieszczyk M, Aden J, Marcus J
Open Forum Infect Dis . 2023 Nov; 10(11):ofad501. PMID: 38023552
Background: Fever and leukocytosis are 2 parameters commonly cited in clinical practice as indications to perform an infectious workup in patients receiving extracorporeal membrane oxygenation (ECMO), but their utility is...
7.
Lee D, Sobieszczyk M, Barsoumian A, Marcus J
Perfusion . 2023 Mar; 39(5):921-926. PMID: 36990456
Introduction: Extracorporeal membrane oxygenation (ECMO) is an increasingly used modality of life support with high risk for nosocomial infections. The accuracy of sepsis prediction tools in identifying blood stream infections...
8.
Marcus J, Ford M, Sattler L, Iqbal S, Garner C, Sobieszczyk M, et al.
Heart Lung . 2023 Mar; 60:15-19. PMID: 36871407
Background: While guidance exists for management of blood stream infections with various invasive devices, there are currently limited data to guide antibiotic selection and duration for bacteremia in patients receiving...
9.
Frankford S, Sobieszczyk M, Markelz A, Marcus J
BMC Infect Dis . 2023 Feb; 23(1):63. PMID: 36732697
Background: There are limited data on the treatment of blood stream infections (BSIs) in patients receiving extracorporeal membrane oxygenation (ECMO). Current guidance recommends documenting clearance only in fungal and Gram-positive...
10.
Ivins-OKeefe K, Cahill M, Mielke A, Sobieszczyk M, Sams V, Mason P, et al.
ASAIO J . 2022 Dec; 68(12):1483-1489. PMID: 36469447
Right heart failure (RHF) is a common, yet difficult to manage, complication of severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation (ECMO) that is associated with increased mortality. Reports...